464 related articles for article (PubMed ID: 16843110)
41. AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2.
Jiao B; Wu CF; Liang Y; Chen HM; Xiong SM; Chen B; Shi JY; Wang YY; Wang JH; Chen Y; Li JM; Gu LJ; Tang JY; Shen ZX; Gu BW; Zhao WL; Chen Z; Chen SJ
Leukemia; 2009 Sep; 23(9):1598-604. PubMed ID: 19458628
[TBL] [Abstract][Full Text] [Related]
42. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
Marcucci G; Livak KJ; Bi W; Strout MP; Bloomfield CD; Caligiuri MA
Leukemia; 1998 Sep; 12(9):1482-9. PubMed ID: 9737700
[TBL] [Abstract][Full Text] [Related]
43. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21).
Vieira L; Oliveira V; Ambrósio AP; Marques B; Pereira AM; Hagemeijer A; Boavida MG
Cancer Genet Cytogenet; 2001 Jul; 128(2):104-7. PubMed ID: 11463447
[TBL] [Abstract][Full Text] [Related]
44. A novel variant translocation t(6;8;21)(p22;q22;q22) leading to AML/ETO fusion in acute myeloid leukemia.
Al Bahar S; Adriana Z; Pandita R
Gulf J Oncolog; 2009 Jan; (5):56-9. PubMed ID: 20084788
[TBL] [Abstract][Full Text] [Related]
45. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia.
Maruyama F; Stass SA; Estey EH; Cork A; Hirano M; Ino T; Freireich EJ; Yang P; Chang KS
Leukemia; 1994 Jan; 8(1):40-5. PubMed ID: 7507193
[TBL] [Abstract][Full Text] [Related]
46. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
Pullarkat ST; Pullarkat V; Lagoo A; Brynes R; Weiss LM; Bedell V; Chen W; Huang Q; Gaal K; Weisenburger DD; Kim YS
Leuk Res; 2013 Nov; 37(11):1572-5. PubMed ID: 24035334
[TBL] [Abstract][Full Text] [Related]
47. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H
Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162
[TBL] [Abstract][Full Text] [Related]
48. Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML.
Cuenco GM; Nucifora G; Ren R
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1760-5. PubMed ID: 10677531
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
Leroy H; de Botton S; Grardel-Duflos N; Darre S; Leleu X; Roumier C; Morschhauser F; Lai JL; Bauters F; Fenaux P; Preudhomme C
Leukemia; 2005 Mar; 19(3):367-72. PubMed ID: 15674426
[TBL] [Abstract][Full Text] [Related]
50. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
[TBL] [Abstract][Full Text] [Related]
51. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
[TBL] [Abstract][Full Text] [Related]
52. Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).
Wang H; Yang W; Shao H; Zhang J; Qi L; Liao A; Li Y; Liu Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):95-8. PubMed ID: 19100512
[TBL] [Abstract][Full Text] [Related]
53. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML).
Agrawal M; Schwarz P; Giaimo BD; Bedzhov I; Corbacioglu A; Weber D; Gaidzik VI; Jahn N; Rücker FG; Schroeder T; Kindler T; Wattad M; Götze K; Lübbert M; Salwender H; Ringhoffer M; Lange E; Koller E; Thol F; Heuser M; Ganser A; Bullinger L; Paschka P; Döhner H; Geiger H; Borggrefe T; Döhner K; Oswald F
Leukemia; 2020 Feb; 34(2):630-634. PubMed ID: 31462736
[No Abstract] [Full Text] [Related]
54. Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1.
Yagyu S; Morimoto A; Kakazu N; Tamura S; Fujiki A; Nakase Y; Iehara T; Hosoi H; Kuroda H
Cancer Genet Cytogenet; 2008 Jan; 180(2):115-20. PubMed ID: 18206536
[TBL] [Abstract][Full Text] [Related]
55. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
[TBL] [Abstract][Full Text] [Related]
56. A novel exon in AML1-ETO negatively influences the clonogenic potential of the t(8;21) in acute myeloid leukemia.
Mannari D; Gascoyne D; Dunne J; Chaplin T; Young B
Leukemia; 2010 Apr; 24(4):891-4. PubMed ID: 20111069
[No Abstract] [Full Text] [Related]
57. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia.
Yamasaki H; Era T; Asou N; Sanada I; Matutes E; Yamaguchi K; Takatsuki K
Leukemia; 1995 Jul; 9(7):1147-53. PubMed ID: 7630188
[TBL] [Abstract][Full Text] [Related]
58. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
[TBL] [Abstract][Full Text] [Related]
59. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.
Krauter J; Wattjes MP; Nagel S; Heidenreich O; Krug U; Kafert S; Bunjes D; Bergmann L; Ganser A; Heil G
Br J Haematol; 1999 Oct; 107(1):80-5. PubMed ID: 10520027
[TBL] [Abstract][Full Text] [Related]
60. Acute myeloid leukaemia with variant t(8;21)(q22;q22) as a result of cryptic ins(8;21).
Wong KF; Siu LL
Pathology; 2011 Feb; 43(2):180-2. PubMed ID: 21233687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
